| Bladder Cancer |
1 |
0.92 |
| Biologic Therapy |
0 |
0.87 |
| Cancer |
0 |
0.72 |
| Toxicology |
0 |
0.65 |
| Adhesion |
0 |
0.27 |
| Bladder |
0 |
0.27 |
| Food and Drug Administration (FDA) |
0 |
0.95 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.19 |
| HIV Infection |
0 |
0.19 |
| Chemotherapy |
0 |
0.18 |
| Clinical Research |
0 |
0.18 |
| Immunotherapy |
0 |
0.18 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.18 |
| Platinum |
0 |
0.18 |
| PubMed |
0 |
0.18 |
| Biopsy |
0 |
0.09 |
| Burnout |
0 |
0.09 |
| Connecticut |
0 |
0.09 |
| Grant |
0 |
0.09 |
| Stevens-Johnson Syndrome |
0 |
0.99 |
| Tissue |
0 |
0.09 |
| Toxic Epidermal Necrolysis |
0 |
0.98 |